$1.66
N/A
Last update: Nov 2, 8:54 AM
OPKO Health Inc (OPK) Stock Price, Quote, News & History
OPKNASDAQ
Labcorp will purchase Myriad Genetics' prenatal testing business for $210 million in cash, projecting $160 million in year-one revenue.
You can purchase shares of OPKO Health (NASDAQ:OPK) through any online brokerage.
Other companies in OPKO Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
OPKO Health has a consensus price target of $2.90.
The stock price for OPKO Health (NASDAQ: OPK) is $1.7 last updated November 2, 2026 at 8:54 AM EST.
There are no upcoming dividends for OPKO Health.
OPKO Health does not have any upcoming earnings scheduled.
There is no upcoming split for OPKO Health.
OPKO Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in...
